Towards gastric cancer screening implementation in the European Union
CONFERENCE
September 7th, 2023
Flanders Meeting & Convention Center | Antwerp, Belgium and on-line
Participants:
- EU country representatives (ministries, national cancer institutes)
- European Council & JRC representatives
- Cancer screening specialists
- Project consortia members (TOGAS, EUROHELICAN, AIDA, PRAISE-U, SOLACE)
- Researchers and opinion leaders involved in gastric cancer prevention
- Patient advocates
08.30 – 10.45 SESSION 1 – STATE OF THE PLAY
08.30 – 08.50 01.01. Global overview of gastric cancer burden and introduction to available preventive strategies
Jin Young Park, Lyon, France
08.50 – 09.10 01.02. The update of gastric cancer prevention in the current guidelines (Maastricht, REGAIN, Taipei)
Peter Malfertheiner, Munich, Germany
09.10 – 09.25 01.03 Gastric precancerous lesions, MAPS guideline
Mário Dinis-Ribeiro, Porto, Portugal
09.25 – 09.45 01.04. Current evidence of the effect and cost-effectiveness of the H. pylori test-and-treat strategy for
gastric cancer prevention
Paul Moayyedi, Hamilton, Canada
09.45 – 10.05 01.05. What we can learn from long-term implementation of a population-based H. pylori eradication
Strategy
Yi-Chia Lee, Taipei, Taiwan
10.05 – 10.20 01.06. Overview of the regular clinical practice of H.pylori management in Europe
Olga P. Nyssen, Madrid, Spain
10.20 – 10.40 Panel Discussion
10.40 – 11.00 Coffee Break
11.00 – 12.10 SESSION 2 – TOGAS PROJECT OVERVIEW
11.00 – 11.15 02.01. Overview of the TOGAS* project
Mārcis Leja, Riga, Latvia
11.15 – 11.30 02.02. Survey on EU member states' need, willingness and readiness to implement a gastric cancer
screening programme
Janet Takens (Thomas More), Antwerp, Belgium
11.30 – 11.45 02.03. Feedback analysis from
(1) the potential individuals to be screened
(3) pilot study representatives and
(4) communicative and cognitive vulnerable populations on the feasibility and acceptability of various
screening strategies (on-line & direct) (Zorana Maravic or Marianna Vitaloni //DiCE) (TBC)
11.45 – 11.55 02.04. Survey of medical professionals
Mārcis Leja, Riga, Latvia
11.55 – 12.10 02.05. Cost-effectiveness analysis – what is required from the MSs
Iris Lansdorp – Vogelaar, Rotterdam, The Netherlands
12.10 – 13.10 Lunch
13.10 – 14.20 SESSION 3: TOGAS: CLINICAL STUDY OVERVIEW
13.10 – 13.25 03.01. Pilot 1. H.pylori screen and treat early at adulthood. EUROHELICAN and TOGAS
Bojan Tepeš, Ljubljana, Slovenia (TBC)
13.25 – 13.40 03.02. Pilot 2. Stomach assessment in subjects undergoing colonoscopy
Jan Bornschein, Oxford, United Kingdom / Riga, Latvia
13.40 – 13.55 03.03. Pilot 3. Addressing the long-term adverse events of H.pylori eradication based on pepsinogen
screening and H.pylori eradication study in middle-aged population
Danute Ražuka-Ebela, Riga, Latvia
13.55 – 14.20 Panel Discussion
Inv. speakers from Sessions 3 & 4
14.20 – 15.10 SESSION 4: EUROPEAN PROCESS OF GUIDELINE DEVELOPMENT
14.20 – 14.30 04.01. Implementation process of EU Mission Recommendations
Christine Chomienne, City
14.30 – 14.45 04.02. Europe’s Beating Cancer Plan: The new EU Cancer Screening Scheme
Matthias Schuppe, Brussels, Belgium (on-line)
14.45 – 15.00 04.03. The EC Knowledge Centre on Cancer and its methodology for developing the Initiatives on
Breast, Colorectal, and Cervical Cancer
Gian Paolo Morgano
15.00 – 15.30 Coffee break
15.30 – 16.50 SESSION 5: TIME FOR GLOBAL ACTION
15.30 – 15.50 05.01. Linque county study status
Wen Qing Li (PI of the Linque county trial), Beijing, China
15.50 – 16.05 05.02. Bhutan experience
Gerwin Winter, City, Germany
16.05 – 16.15 05.03. Experience with endoscopic gastroesophageal cancer screening in Kazakhstan (2013-2017)
Alma Zhylkaidarova, Almaty, Kazakhstan
16.15 – 16.30 05.04. Overview of gastric cancer prevention programmes in Latin America
Constanza Camargo, Rockville, MD, USA
16.30 – 16.45 05.05. Is there a place for AI in cancer prediction: AIDA efforts
Tania Fleitas Kanonnikoff, Valencia, Spain (online)
16.45 – 17.00 06.06. CARECOL data collaborative
Inese Poļaka, Riga, Latvia
17.00 – 18.00 SESSION 6: COUNTRY RELATED ISSUES, FEEDBACK, DISCUSSION
17.00 – 17.10 06.02. Experience with the survey of medical professionals in Azerbaijan
Gulustan Babajeva, Baku, Azerbaijan
17.10 – 17.15 ……
17.15 – 17.20 ……
17.20 – 17.25 ……
17.25 – 17.30 ……
17.35 – 17.40 …….
17.40 – 18.00 General Discussion (30 min)
* This project has received funding from the European Union programme EU4Health under Grant Agreement No 101101252.
* Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily
reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for
them.
Riga, 08 June 2023
CONFERENCE INVITATION
TO THE REPRESENTATIVES FROM THE EU MEMBER STATES
Dear Sir/Madam,
The 2022 European “Council Recommendation on strengthening prevention through early detection:
a new EU approach on cancer screening” is recommending implementation of three new cancer
screening programs, including for gastric cancer, in the European Union.
TOGAS project* (“Towards gastric cancer screening implementation in the European Union”) is
addressing implementation of gastric cancer screening. For this, we consider the exchange of
information with the EU Member States to be of utmost importance.
Therefore, it is our great pleasure to invite representatives from the Member States, national
screening experts and patient advocates to participate in the Conference
“Towards gastric cancer screening implementation in the
European Union”
to be held on September 7, 2023 in the Flanders Meeting & Convention Center Antwerp, Belgium.
The purpose of this conference is to inform the participants on the current evidence related to gastric
cancer prevention as well as gather feedback from EU Member States on the needs and potential
barriers for streamlining gastric cancer screening. We encourage policymakers, screening experts,
epidemiologists, medical specialists, as well as patient representatives, to participate in person and
share their insights, experiences, and expertise.
We look forward to your participation at the conference and to the fruitful discussions and
collaborations that will undoubtedly arise from this gathering. Together, let us work towards
improving gastric cancer prevention and screening practices across Europe, with the ultimate aim of
reducing the burden of this devastating disease.
The conference will feature live video streaming.
To confirm your attendance, kindly complete the registration form
http://bit.ly/TOGAS_conference23
no later than 30th June 2023. Should you have any questions or require further information, please do
not hesitate to contact Patrícia Carneiro at
[email protected] or
[email protected].
Yours sincerely,
Mārcis Leja
Project Coordinator
* This project has received funding from the European Union programme EU4Health under Grant Agreement No 101101252.
* Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not
necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be
held responsible for them.
Saatja: Patricia Carneiro <
[email protected]>
Saadetud: 13.06.2023 19:22
Adressaat: TOGAS <
[email protected]>
Koopia: Mārcis Leja <
[email protected]>; Dina Bēma <
[email protected]>
Teema: Invitation for conference on gastic cancer screening
implementation
Tähtsus: Kõrgeim
Dear Sir/Madam,
It is with great pleasure that we announce the Conference Towards gastric
cancer screening implementation in the European Union to be held on
September 7 in Flanders Meeting & Convention Center Antwerp, Belgium.
The "Towards gastric cancer screening implementation in the European
Union" (TOGAS) project* is addressing implementation of gastric
cancer screening, according to the 2022 European Council Recommendation
on strengthening prevention through early detection: A new EU approach on
cancer screening. For this, we regard the exchange of information with
the EU Member States to be of paramount importance.
We kindly invite representatives from the Member States, national
screening experts and patient advocates to discuss EU´s perspective on
gastric cancer screening implementation. We will be addressing a variety
of questions to provide clear recommendations for screening practices
across Europe.
We greatly appreciate your consideration and look forward to your active
participation in the conference by preparing a short PowerPoint
presentation for the last session of the conference.
Please find attached the invitation letter to the conference and the
respective agenda.
The conference will feature live video streaming.
Thank you in advance for your support. We hope to showcase your
contribution during this significant event.
Best regards,
Mârcis Leja
TOGAS coordinator
* This project has received funding from the European Union programme
EU4Health under Grant Agreement No 101101252.
* Funded by the European Union. Views and opinions expressed are however
those of the author(s) only and do not necessarily reflect those of the
European Union or HaDEA. Neither the European Union nor the granting
authority can be held responsible for them.